ibrutinib
janssen,abbvie
['ibru', 'cll']
excited to present our most recent multicenter collaborative #cll work at the #eha2022 meeting today: "effective treatments for hypertension (htn) in patients treated with ibrutinib (ib)." (1/4) #cardiooncology 
Associate Professor,  Fred Hutch Cancer Center, U of Washington. Lymphoma/CLL. Targeted therapy/Cellular therapy (CAR-T, Transplant)